SCMP Financial Facts
Interest expense: -5.9MContract and collaboration revenue: 2.38M
See Full Income Statement
Accounts receivable, net: 20.68M
Accounts payable: 7.87M
See Full Balance Sheet
Sucampo Pharmaceuticals (SCMP) Earnings
|
Expand Research on SCMP
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -2.4% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/3/11 | Q410 | -$0.15 | -$0.01 | -$0.14 | $12.4M | $15.5M | N/A | Details | |||
11/3/11 | Q311 | -$0.10 | N/A | N/A | $14.37M | $20.9M | N/A | Details | |||
3/13/12 | Q411 | $0.06 | N/A | N/A | $14.22M | $15.9M | N/A | Details | |||
3/13/13 | Q412 | $0.32 | $0.12 | +$0.20 | $34.9M | $32.21M | N/A | Details | |||
5/7/14 | Q113 | $0.02 | $0.04 | -$0.02 | $22.2M | $24.19M | N/A | Details | |||
8/5/14 | Q213 | $0.04 | $0.03 | +$0.01 | $24.1M | $24.06M | N/A | Details | |||
11/6/14 | Q313 | $0.03 | $0.04 | -$0.01 | $31.5M | $26.11M | N/A | Details | |||
3/4/15 | Q413 | $0.21 | $0.18 | +$0.03 | $37.8M | $37.23M | = | Details |